Emile Voest

Emile Voest

More and more cancer drugs are only suitable for a small group of patients. However, we are often not capable to find these patients. That is why every patient with metastatic cancer should be genetically screened before starting treatment.

Back to news

More news

Collaboration between Hartwig and CKB makes both parties stronger 

Collaboration between Hartwig and CKB makes both parties stronger 

13-06-2023

Hartwig Medical Foundation has worked with The Jackson Laboratory (JAX) Clinical Knowledgebase (CKB) team since 2020, to the benefit of …

Complete DNA analysis for young adults with cancer

Complete DNA analysis for young adults with cancer

06-01-2022

KWF finances the expansion of the infrastructure for cancer research in young adults with almost 4.5 million euros. These are …

Patients can benefit from whole genome sequencing for immunotherapy

Patients can benefit from whole genome sequencing for immunotherapy

01-10-2020

Immunotherapy is an effective treatment for many people with cancer. The number of abnormalities in the DNA of the tumor in …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl